Clinical Trial Update: Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of ophthalmic phentolamine mesylate to reverse pharmacologically induced mydriasis has completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilation of Pupil
• Mydriasis

Drugs mentioned

• phentolamine mesylate (ophthalmic) (phentolamine mesylate)

Snippet

Sponsor: Ocuphire Pharma, Inc. | Conditions: Mydriasis, Dilation | Phase 2 | Status: COMPLETED | Results posted: 2022-08-15